Tenax Therapeutics
TENX
1 hedge funds and large institutions have $55K invested in Tenax Therapeutics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
686% more capital invested
Capital invested by funds: $7K → $55K (+$48K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $54K | +$59K | +1 | New |
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| – | -$1K | – | – |
|
TENX Hedge Fund Activity: Q3 2013 in Review
1 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2013, worth a combined $55K — up 686% from $7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TENX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $59K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1K.
- 1 institutional investor held Tenax Therapeutics (TENX) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $55K of Tenax Therapeutics stock for Q3 2013, up 686% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q3 2013 and 0 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q3 2013 was Sabby Management, an estimated $59K added.
- The largest Tenax Therapeutics seller in Q3 2013 was Tower Research Capital (TRC), an estimated $1K sold.
Based on aggregated 13F filings for Q3 2013.